Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Peptide mimicry breaks the heart: Myocarditis, a prolonged chronic inflammation of heart muscle, can eventually progress to inflammatory cardiomyopathy, a serious condition associated with heart failure. Activated T helper (T H ) cells that recognize myosin heavy chain 6–derived peptides are thought to play a central role in this pathogenesis. Using a mouse model of myocarditis, Gil-Cruz et al. found that cardiac myosin–reactive T H cells are initially primed by myosin-peptide mimics derived from commensal Bacteroides species in the gut (see the Perspective by Epelman). Unlike heathy controls, human myocarditis patients also showed detectable immune reactivity to both Bacteroides and cardiac myosin antigens. Treatment with antibiotics dampened inflammatory responses and prevented lethal heart disease. Science , this issue p. 881 ; see also p. 806
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cross-reactivity of α -MyHC-specific T cells is further supported by findings that these T cells also recognize commensal Bacteroides species. 283”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [283]
In the citing paper
“Animal models of myocarditis have yielded a wealth of information about the pathogenesis of disease including a number of landmark articles that demonstrate that myocarditis is an autoimmune disease that requires TLR activation by microbes. 44,152,153”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [44]
In the citing paper
“Yet recent data identified cross-reactivity between a B. thetaiotaomicron β–galactosidase and myosin peptide associated with development of cardiomyopathy in genetically susceptible individuals (31).”
From A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors (2021) · cites this paper as [31]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.007 · Cited by 1,289
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 649
Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A
Bunker, J. J., Flynn, T. M., Koval, J. C., Shaw, D. G., Meisel, M., McDonald, B. D., Ishizuka, I. E., Dent, A. L., Wilson, P. C., Jabri, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.007 · Cited by 555
Guidelines for the use of flow cytometry and cell sorting in immunological studies *
Cossarizza, A., Chang, H., Radbruch, A., Akdis, M., Andrä, I., Annunziato, F., Bacher, P., Barnaba, V., Battistini, L., Bauer, W. M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646632 · Cited by 542
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cited by
Items 101–200 of 264
A cardioimmunologist’s toolkit: genetic tools to dissect immune cells in cardiac disease
Wong, A., Hamidzada, H., & Epelman, S. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00701-0 · Cited by 32
Drapkina, O. M., Yafarova, A. A., Kaburova, A. N., & Kiselev, A. R. (2022) · Biomedicines · doi:10.3390/biomedicines10082019 · Cited by 29
“theta-specific antibodies and disease progression and severity [70].”
BackgroundMicrobiota as Drivers and as Therapeutic Targets in Ocular and Tissue Specific Autoimmunity
Salvador, R., Zhang, A., Horai, R., & Caspi, R. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.606751 · Cited by 26
The impact of the gut microbiota on T cell ontogeny in the thymus
Nanjundappa, R. H., Umeshappa, C. S., & Geuking, M. B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04252-y · Cited by 32
“Similarly, Bacteroides thetaiotaomicron expresses a peptide mimic to myosin heavy chain 6 (MYH6) a motor protein in humans that activates CD4+ T cell response and promotes cardiomyopathy [147].”
BackgroundSelf-citationEnglish, J., Patrick, S., & Stewart, L. D. (2023) · Anaerobe · doi:10.1016/j.anaerobe.2023.102721 · Cited by 28
Gouttefangeas, C., Klein, R., & Maia, A. R. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212546 · Cited by 28
Huang, J., Gong, C., & Zhou, A. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231204854 · Cited by 33
“133,134 Microbial-specific T lymphocytes can activate an effective antitumor immune response.”
BackgroundMitochondrial extracellular vesicles, autoimmunity and myocarditis
Florio, D. N. D., Beetler, D. J., McCabe, E. J., Sin, J., Ikezu, T., & Fairweather, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374796 · Cited by 30
“…between the two conditions is not clear-cut because patients with viral myocarditis and mouse models of viral myocarditis have been demonstrated to develop autoantibodies and autoreactive T and B cells against cardiac myosin and other self-antigens including mitochondria (2, 39, 79, 81 – 83).”
BackgroundCross-reactivity between cancer and microbial antigens
Zitvogel, L., & Kroemer, G. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1877416 · Cited by 25
“An inflammatory cardiopathy has been causally related to Bacteroides species producing a ß-galactosidase cross-reactive with an HLA-DQB1*-restricted peptide from human myosin heavy chain 6.(6) Multiple sclerosis (MS) has been epidemiologically associated with the presence of Akkermansia muciniphila in the gut, and HLA…”
BackgroundIleal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
Picard, M., Yonekura, S., Slowicka, K., Petta, I., Rauber, C., Routy, B., Richard, C., Iebba, V., Tidjani Alou, M., Becharef, S., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00684-w · Cited by 24
Tomasi, M., Caproni, E., Benedet, M., Zanella, I., Giorgetta, S., Dalsass, M., König, E., Gagliardi, A., Fantappiè, L., Berti, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.912639 · Cited by 25
“More recently, it has been proposed that mimic peptides from commensal bacteria can promote inflammatory cardiomyopathy in genetically susceptible individuals, leading to myocarditis and lethal heart disease (13).”
BackgroundHapke, N., Heinrichs, M., Ashour, D., Vogel, E., Hofmann, U., Frantz, S., & Ramos, G. C. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.09.001 · Cited by 24
Self-citationBondareva, M. A., Budzinski, L., Durek, P., Witkowski, M., Angermair, S., Ninnemann, J., Kreye, J., Letz, P., Ferreira‐Gomes, M., Semin, I. K., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.10.007 · Cited by 24
Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy
Tajiri, K., Yonebayashi, S., Li, S., & Ieda, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624703 · Cited by 23
“(35) demonstrated that the commensal gut microbe Bacteroides thetaiotaomicron (B.”
BackgroundPrecision strategies for cancer treatment by modifying the tumor-related bacteria
Lu, H., Wang, Q., Liu, W., Wen, Z., & Li, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11491-9 · Cited by 22
Laino, M. E., Ammirabile, A., Motta, F., Santis, M. D., Savevski, V., Francone, M., Chiti, A., Mannelli, L., Selmi, C. F., & Monti, L. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08925-1 · Cited by 16
Ma, X., Zhang, J., Jiang, Q., Li, Y., & Yang, G. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105516 · Cited by 22
Immune cells and related cytokines in dilated cardiomyopathy
Zhang, J., Cheng, L., Li, Z., Li, H., Liu, Y., Zhan, H., Xu, H., Huang, Y., Feng, F., & Li, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116159 · Cited by 22
Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case
Vannella, K. M., Oguz, C., Stein, S. R., Pittaluga, S., Dikoglu, E., Kanwal, A. S., Ramelli, S. C., Briese, T., Su, L., Wu, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.779026 · Cited by 20
The Role of Gut Microbiota in Modulating Immune Signaling Pathways in Autoimmune Diseases
Younis, N. K., Alfarttoosi, K. H., Sanghvi, G. V., Roopashree, R., Kashyap, A., Krithiga, T., Taher, W. M., Alwan, M., Jawad, M. J., & Al-Nuaimi, A. M. A. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08883-9 · Cited by 22
Wang, S., Peng, D., Zhu, H. S., Min, W., Xue, M., Wu, R., Shao, Y., Pan, L., & Zhu, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1053370 · Cited by 21
“The gut microbiome has been suggested to contribute to experimental irAEs (41, 42) and colitis in melanoma patients (43–45).”
BackgroundPolyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging
Pereira, Q. C., Fortunato, I. M., Oliveira, F. D. S., Alvarez, M. C., dos Santos, T. W., & Ribeiro, M. L. (2024) · Nutrients · doi:10.3390/nu16071066 · Cited by 19
Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance
Liu, Y., Zhou, J., Yang, Y., Chen, X., Chen, L., & Wu, Y. (2024) · Vaccines · doi:10.3390/vaccines12080868 · Cited by 20
Myocardial-Treg Crosstalk: How to Tame a Wolf
Weiß, E., Ramos, G. C., & Delgobo, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914033 · Cited by 20
“Strikingly, the transgenic mice bearing TCR-M cells developed spontaneous autoimmune myocarditis via a microbiota peptide mimicry and TH17 polarization, illustrating how different contexts shape the T-cell phenotypes (39).”
BackgroundSelf-citationUncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review
Halsey, T. M., Ologun, G. O., Wargo, J. A., & Jenq, R. R. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.05.002 · Cited by 19
Wang, Y., Singh, K., Lokman, A. B., Deng, S., Sunitha, B., Lima, J. C., Jr., Beglov, J., Kelly, M., Blease, A., Fung, J. C. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3516 · Cited by 19
Microbiota‐related metabolites fueling the understanding of ischemic heart disease
Fan, Y., Ying, J., Ma, H., & Cui, H. (2023) · iMeta · doi:10.1002/imt2.94 · Cited by 18
Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology
Chen, M., Xue, J., Wang, M., Yang, J., & Chen, T. (2023) · Cancers · doi:10.3390/cancers15113055 · Cited by 18
Autoimmune-Like Mechanism in Heart Failure Enables Preventive Vaccine Therapy
Martini, E., Cremonesi, M., Felicetta, A., Serio, S., Puccio, S., Pelamatti, E., van Beek, J. J. P., Papadopoulou, V., Catalano, C., Fanuele, F., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324999 · Cited by 18
Sagmeister, A., Matter, C. M., Stähli, B. E., & Scharl, M. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413529 · Cited by 19
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
Tomasi, M., Dalsass, M., Beghini, F., Zanella, I., Caproni, E., Fantappiè, L., Gagliardi, A., Irene, C., König, E., Frattini, L. F., et al. (2021) · Vaccines · doi:10.3390/vaccines9111356 · Cited by 21
“More recently, it has been elegantly proposed, using a mouse model of spontaneous autoimmune myocarditis, that mimic peptides from commensal bacteria can promote inflammatory cardiomyopathy in genetically susceptible individuals, leading to myocarditis and lethal heart disease [52].”
BackgroundThe oft-overlooked cardiovascular complications of inflammatory bowel disease
Massironi, S., Mulinacci, G., Gallo, C., Viganò, C., Fichera, M., Villatore, A., Peretto, G., & Danese, S. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2174971 · Cited by 22
“Recently, it has been suggested that myosin 6 antigens and myosin peptide mimics from commensal intestinal Bacteroides species can promote inflammatory cardiomyopathy in genetically susceptible individuals, highlighting the importance of the heart-gut crosstalk [77].”
BackgroundWang, J., Zhang, X., Yang, X., Yu, H., Bu, M.-M., Fu, J., Zhang, Z., Xu, H., Hu, J., Lu, J., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1191936 · Cited by 21
“Acute myocarditis patients have increased antiBacteroides IgG and cross-reactive T cell activation (Gil-Cruz et al., 2019).”
BackgroundRacine, J. J., Bachman, J. F., Zhang, J.-G., Misherghi, A., Khadour, R., Kaisar, S., Bedard, O., Jenkins, C., Abbott, A., Forte, E., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300841 · Cited by 17
Myocarditis and Inflammatory Cardiomyopathy in Dilated Heart Failure
Nappi, F. (2025) · Viruses · doi:10.3390/v17040484 · Cited by 18
Relman, D. A. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.01.018 · Cited by 20
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
Vergara, A., Felice, M. D., Cesaro, A., Gragnano, F., Pariggiano, I., Golia, E., Pasquale, A. D., Blasi, E., Fimiani, F., Monda, E., et al. (2023) · Angiology · doi:10.1177/00033197231201929 · Cited by 17
Immunodietica: interrogating the role of diet in autoimmune disease
Gershteyn, I. M., Burov, A. A., Miao, B. Y., Morais, V. H., & Ferreira, L. M. R. (2020) · International Immunology · doi:10.1093/intimm/dxaa054 · Cited by 17
Piccioni, A., Saviano, A., Cicchinelli, S., Franza, L., Rosa, F., Zanza, C., Santoro, M. C., Candelli, M., Covino, M., Nannini, G., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091234 · Cited by 15
“These peptides can cross-activate T-lymphocytes (Th1 and Th17 more specifically), promoting cardiotoxic damage [62].”
BackgroundThe role of the intestinal microbiome in antiphospholipid syndrome
van Mourik, D. J. M., Salet, D. M., Middeldorp, S., Nieuwdorp, M., & van Mens, T. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954764 · Cited by 14
“A broad-spectrum antibiotic was also used in a transgenic spontaneous autoimmune myocarditis mouse model and again showed protective effects (18).”
BackgroundInfluentialHow can we manage the cardiac toxicity of immune checkpoint inhibitors?
Poto, R., Marone, G., Pirozzi, F., Galdiero, M. R., Cuomo, A., Formisano, L., Bianco, R., Corte, C. M. D., Morgillo, F., Napolitano, S., et al. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1906860 · Cited by 14
“Also, impaired thymic tolerance to myosin antigens is potential mechanism of development for ICI related cardiovascular irAEs [66], and furthermore Gil-Cruz and colleagues [67] demonstrated that progression of autoimmune myocarditis to lethal heart disease depends on cardiac myosin-specific Th17 cells imprinted in the…”
BackgroundČiháková, D., Shi, Y., Adhikari, B., Bandettini, W. P., Cunningham, M. W., Danthi, N., Friedrich, M. G., Liu, P., Longacre, L. S., Mann, D. L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195721 · Cited by 13
“In addition, environmental influences can promote inflammatory responses, especially in genetically susceptible individuals, as recently demonstrated in the activation of cardiac myosin-specific T-helper cells in the intestine by a mimic peptide from a common commensal Bacteroides species in patients with particular H…”
BackgroundImmune communication between the intestinal microbiota and the cardiovascular system
Ren, H., Zhu, B., An, Y., Xie, F., Wang, Y., & Tan, Y. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.01.007 · Cited by 13
Microbiome modulation of antigen presentation in tolerance and inflammation
He, Y., Mohapatra, G., Asokan, S., Nobs, S. P., & Elinav, E. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102471 · Cited by 13
Myosin-Specific T Cells in Myocardial Diseases Revisited
Ramos, G. C., Frantz, S., & Hofmann, U. (2023) · Circulation · doi:10.1161/circulationaha.123.064453 · Cited by 13
Self-citationyuzefpolskaya, M., Bohn, B., Ladanyi, A., Khoruts, A., Colombo, P. C., & Demmer, R. T. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.12.009 · Cited by 13
Kallikourdis, M., Cochran, J. D., Walsh, K. X., & Condorelli, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325489 · Cited by 13
Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor‐Associated Myocarditis
Jo, W., Sun, V., & Čiháková, D. (2026) · Immunological Reviews · doi:10.1111/imr.70111 · Cited by 12
Panagiotides, N. G., Poledniczek, M., Andreas, M., Hülsmann, M., Kocher, A. A., Kopp, C. W., Piechota-Polańczyk, A., Weidenhammer, A., Pávó, N., & Wadowski, P. P. (2024) · Viruses · doi:10.3390/v16010121 · Cited by 13
yuzefpolskaya, M., Lumish, H. S., Javaid, A., Cagliostro, B., Mondellini, G. M., Bohn, B., Sweat, A. O., Onat, D., Braghieri, L., Takeda, K., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2215 · Cited by 13
Pamungkas, K. M. N., Dewi, P. I. S. L., Alamsyah, A. Z., Dewi, N. L. P. Y., Dewi, N. N. G. K., Mariadi, I. K., & Sindhughosa, D. A. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106810 · Cited by 11
Mindur, J. E., Yadav, S. K., Ito, N., Senoh, M., Kato, H., Dhib-Jalbut, S. S., & Ito, K. (2020) · Microorganisms · doi:10.3390/microorganisms9010034 · Cited by 11
Liu, L., Huang, J., Liu, Y., Pan, X., Li, Z., Zhou, L., Lai, T., Chen, C., Wei, B., Mo, J., et al. (2021) · BioMed Research International · doi:10.1155/2021/6653802 · Cited by 12
“GO:0044389 Ubiquitin−like protein ligase binding [12] GO:0019199 Transmembrane receptor protein kinase activity [6] GO:0004709 MAP kinase kinase kinase activity [6] GO:0016772 Transferase activity, transferring phosphorus−containing groups [26] GO:0019901 Protein kinase binding [20] GO:0004714 Transmembrane receptor p…”
BackgroundRetractedPedicino, D., Severino, A., Sante, G. D., Rosa, M. C. D., Pirolli, D., Vinci, R., Pazzano, V., Giglio, A. F., Trotta, F., Russo, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845526 · Cited by 11
“Moreover, in agreement with our findings, another study has recently described the involvement and the activation of heart-specific Th cells by bacterial peptide mimics derived from the intestinal microbiota, able to enter the myocardium, enhancing the damage caused by infection during lethal inflammatory cardiomyopat…”
ResultHan, B., Wang, L., Wang, X., Gu, L., & Yuan, W. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03101-22 · Cited by 12
Zhao, N., Ma, Y., Liang, X., Zhang, Y., Hong, D., Wang, Y., & Bai, D. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s396649 · Cited by 11
“Gil-Cruz 33 found that symbiotic Bacteroides triggered a cross-immune response against bacterial proteins and cardiac epitopes, leading to cardiomyopathy.”
Acromegaly is associated with a distinct oral and gut microbiota
Şahin, S., Gündoğdu, A., Nalbantoglu, U., Kadıoğlu, P., Karaca, Z., Hacıoğlu, A., Urhan, M. E., Ünlühızarcı, K., Demir, A. N., Hora, M., et al. (2022) · Pituitary · doi:10.1007/s11102-022-01223-1 · Cited by 11
Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors
van der Vegt, S. A., Polonchuk, L., Wang, K., Waters, S. L., & Baker, R. E. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.111002 · Cited by 13
Peretto, G., Villatore, A., & Cooper, L. T. (2026) · Immunological Reviews · doi:10.1111/imr.70105 · Cited by 10
“A compelling mechanistic illustration comes from molecular mimicry between a peptide from Bacteroides species and the human MYH6(614–629) cardiac myosin epitope; this mimic peptide binds permissive HLA-DQA1/B1 molecules and primes autoreactive CD4+ T cells, promoting fulminant myocarditis [18].”
Peripheral immune mapping and multi-omics analysis in Pd -1 inhibitor–induced myocarditis
Gao, J., Wang, Y., Lü, L., Ma, M., Ling, J., Sun, L., Chen, Y., Liu, F., Yu, Y., Liu, T., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad056 · Cited by 11
Xuan, Y., Gao, X., Wang, J., Li, H., Zhou, Z., Liao, M., Zheng, W., & Wang, D. W. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70028 · Cited by 11
Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies
Tang, W. H. W., & Prasad, S. V. N. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001264 · Cited by 11
Zhang, L., Jin, G., & Li, D. (2022) · Cancers · doi:10.3390/cancers14225710 · Cited by 10
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Elsanhoury, A., Tschöpe, C., & Linthout, S. V. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10025-4 · Cited by 11
“[146] showed that broad-spectrum antibiotic treatment could dampen TH cell-mediated cardiac inflammatory responses, trigged by commensal Bacteroides theca mimic peptides.”
BackgroundCiccarelli, M., Falcão‐Pires, I., Bauersachs, J. K., Bertrand, L., Beauloye, C., Dawson, D. K., Hamdani, N., Hilfiker‐Kleiner, D., Laake, L. W. V., Lezoualc’h, F., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad088 · Cited by 11
Diet, inflammation, and cardiovascular disease
Vahid, F., Chiriboga, D. E., Bohn, T., & Hébert, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00015-6 · Cited by 10
Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
Li, B., Gong, T., Hao, Y., Zhou, X., & Cheng, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.721249 · Cited by 9
The distinct functions of MIF in inflammatory cardiomyopathy
Pressley, K. R., Naseem, Y., Nalawade, S. A., & Forsthuber, T. G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544484 · Cited by 9
“Moreover, patients with ICM have detectable immune reactivity to both myosin 6 antigens and myosin peptide mimics derived from commensal Bacteroides species from the gut (55).”
T cells in acute and chronic myocarditis: from diagnosis to treatment
Song, E. J., Joachimbauer, A., Tasca, S., Baylis, R. A., Schmidt, D., Ludewig, B., & Moslehi, J. J. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehaf1080 · Cited by 11
“CD4 + T effector cells in the myocardium produce interferon-gamma (IFN-γ ) following recognition of cardiac antigen presented by cardiac dendritic cells 25,26 and thereby foster cardiomyocyte-damaging activity of inflammatory macrophages 21 ( Figure 2D ).”
InfluentialSelf-citationRoessler, J., Zimmermann, F., Heidecker, B., Landmesser, U., & Haghikia, A. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14991 · Cited by 10
van der Vegt, S. A., Wang, Y., Polonchuk, L., Wang, K., Waters, S. L., & Baker, R. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.966180 · Cited by 9
“As MyHCα is only present at very low levels in the thymus, T cells with TCRs specific to this antigen are not completely removed and MyHCα-specific T cells are known to be in circulation in humans (Lichtman, 2013; Błyszczuk, 2019; Gil-Cruz et al., 2019).”
BackgroundWu, Y., Deng, N., Liu, J., Jiang, P., & Tan, Z. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1288430 · Cited by 8
Data-driven microbiota biomarker discovery for personalized drug therapy of cardiovascular disease
Shen, L., Shen, K., Bai, J., Wang, J., Singla, R. K., & Shen, B. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105225 · Cited by 8
Cao, H., Dai, H., Li, S., Afzal, Z., Wang, X., Wen, Z., Xiao, K., Zhao, Y., Li, J., & Yang, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-05635-4 · Cited by 10
“Myosin-peptide mimics derived from gut bacteria can promote autoimmune response against ◂ the heart 30,31 .”
Girdhar, K., Randall, A., Mine, K., Howard, C., Pezzella, A., Dogru, D., Rhodes, L., James, B., Gautam, U. K., Šrůtková, D., et al. (2025) · Journal of Molecular Endocrinology · doi:10.1530/jme-25-0025 · Cited by 7
“While molecular mimicry has long been postulated as a potential factor in autoimmune diseases (Harkiolaki et al. 2009, Greiling et al. 2018, Gil-Cruz et al. 2019), including T1D (Atkinson et al. 1994, Tian et al. 1994, Honeyman et al. 2010) (coxsackie B and rubella viruses), progress was hindered…”
Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy
Zhang, T., Zhang, X., Chen, J., Zhang, X., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411490 · Cited by 10
Myocarditis in the forensic setting – a review of the literature
Oyarzun, A., Parsons, S. A., & Bassed, R. (2022) · Cardiovascular Pathology · doi:10.1016/j.carpath.2022.107475 · Cited by 9
Alterations of the gut microbiome and metabolic profile in CVB3-induced mice acute viral myocarditis
Kong, Q., Chen, L., Zeng, X., Lu, F., Huang, Y., & Wu, W. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02863-4 · Cited by 7
“Cardiac inflammation of experimental autoimmune myocarditis (EAM) was induced by bacterial peptide mimics, which was derived from the intestinal microbiota [22].”
BackgroundYoon, K., Lee, S. J., Keum, G. B., Song, K.-Y., Park, J., Song, B., Yu, S. Y., Cho, J. H., Kim, E. S., Doo, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01334-23 · Cited by 7
“The metabolomic alterations due to LPL97 could offer a more comprehensive understanding of its interactions with host systems and their resulting consequences (95, 96).”
BackgroundMerlo, M., Bassetto, G., Cannata, A. N., Aimo, A., Autore, C., Bauce, B., Biagini, E., Cappelli, F., Castelletti, S., D’Ascenzi, F., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15231 · Cited by 7
Th17 Cells in Cardiovascular Disease
Yang, K., Liu, Q., Fan, A., Lin, H., Wang, X., Cui, T., Fan, G., & Li, L. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70069 · Cited by 7
Dai, L., Duan, Y., & Xiong, Q. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13697 · Cited by 7
“Furthermore, variations in gut microbiota composition among patients may modu‑ late these immune responses, thereby influencing disease susceptibility (89,116).”
Peretti, S., Torracchi, S., Russo, E., Bonomi, F., Fiorentini, E., Aoufy, K. E., Bruni, C., Lepri, G., Orlandi, M., Chimenti, M. S., et al. (2022) · Genes · doi:10.3390/genes14010089 · Cited by 7
Sun, J., Yao, J., Olén, O., Halfvarson, J., Bergman, D., Ebrahimi, F., Roelstraete, B., Rosengren, A., Sundström, J., & Ludvigsson, J. F. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002701 · Cited by 6
Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements
Khidirova, L. D., Latsvieva, A. E., & Vederin, A. V. (2024) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2024-3022 · Cited by 6
Impact of gut microbiota on cardiac aging
Yin, Z., Fu, L., Wang, Y., & Tai, S. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105639 · Cited by 7
Gonçalves, P., Daker, S. E., Vasseur, F., Serafini, N., Lim, A., Azogui, O., Decaluwe, H., Guy‐Grand, D., Freitas, A. A., Santo, J. P. D., et al. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.05.012 · Cited by 6
Gut Microbiome of a Multiethnic Community Possessed No Predominant Microbiota
Khine, W. W. T., Teo, A. H. T., Loong, L. W. W., Tan, J. J. H., Ang, C. G. H., Ng, W., Lee, C. N., Zhu, C., Lau, Q. C., & Lee, Y. K. (2021) · Microorganisms · doi:10.3390/microorganisms9040702 · Cited by 6
“These include arterial diseases [32,33], type-2 diabetes [34,35], colorectal cancer [36–38], cardiomyopathy [39],”
BackgroundRegulation of Host Immunity by the Gut Microbiota
Partney, H., & Yissachar, N. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_4 · Cited by 7
Ninnemann, J., Budzinski, L., Bondareva, M. A., Witkowski, M., Angermair, S., Kreye, J., Durek, P., Reincke, S. M., Sánchez-Sendín, E., Yilmaz, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.08.455272 · Cited by 6
Root-Bernstein, R. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031797 · Cited by 6
“A wide range of pneumococcal vaccines already exist, but ongoing efforts are underway to develop S. pyogenes and other Group A Streptococcal vaccines, particularly for the prevention of myocardial disease sequelae in high-incidence areas of the world [221–223].”
BackgroundIn Silico Modeling of COVID-19 Pandemic Course Differentiation Using the FOD Model
Roterman, I., Stąpor, K., Fabian, P., & Konieczny, L. (2022) · Coronaviruses · doi:10.2174/2666796703666220602155421 · Cited by 8
Cardioimmunology: the new frontier!
Sattler, S., Ramos, G. C., Ludewig, B., & Rainer, P. P. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad230 · Cited by 5
Self-citationCoping with sterile inflammation: between risk and necessity
Ashour, D., Delgobo, M., Frantz, S., & Ramos, G. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab157 · Cited by 5
“are kept at levels far below to those seen in pathogenic autoimmune myocarditis.(8,9)”
BackgroundSelf-citationTracking antigen-specific T cell responses in patients with myocardial infarctionPreprint
Rizakou, A., Bauer, M., Delgobo, M., Hofmann, A., Heinrichs, M., Siegel, J., Krammer, T., Saliba, A., Gouge, K. L., Jahns, R., et al. (2025) · medRxiv · doi:10.1101/2025.06.05.25328514 · Cited by 5
Self-citationZhang, N., Wang, Y., Luo, G., & Gao, X. (2026) · Nutrients · doi:10.3390/nu18111659 · Cited by 4
Carbohydrate Deacetylase Unique to Gut Microbe Bacteroides Reveals Atypical Structure
Schwartz, L., Norman, J. O., Hasan, S., Adamek, O. E., Dzuong, E., Lowenstein, J. C., Yost, O. G., Sankaran, B., & McLaughlin, K. J. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00519 · Cited by 5
Chen, Y., Chen, J., & Li, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001199 · Cited by 5
Ozkan, J. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab396 · Cited by 4
Rise of Bacterial Small Proteins and Peptides in Therapeutic Applications
Meenakshi, S., & Shelin, R. (2023) · Protein and Peptide Letters · doi:10.2174/0929866530666230118144723 · Cited by 5
Metadata
- Authors
- Gil-Cruz, C., Perez-Shibayama, C., De Martin, A., Ronchi, F., van der Borght, K., Niederer, R., Onder, L., Lütge, M., Novkovic, M., Nindl, V., Ramos, G., Arnoldini, M., Slack, E. M. C., Boivin-Jahns, V., Jahns, R., Wyss, M., Mooser, C., Lambrecht, B. N., Maeder, M. T., Rickli, H., Flatz, L., Eriksson, U., Geuking, M. B., McCoy, K. D., & Ludewig, B.
- Affiliations
- Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
- University of Bern (CH)
- VIB Center for Inflammation Research, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
- Kantonsspital St. Gallen (CH)
- Universitätsklinikum Würzburg (DE)
- ETH Zurich (CH)
- Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.
- University of Calgary (CA)
- Ghent University (BE)
- University of Zurich (CH)
- Corresponding author
- Ludewig, Burkhard
- ORCID
- Venue
- Science
- Published
- 2019-11-15
- Volume
- 366
- Issue
- 6467
- Pages
- 881-886
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2988477155
- Cited by
- 260
- References
- 38
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 51 · 2022: 49 · 2021: 37 · 2020: 31 · 2019: 3
- FWCI
- 21.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Swiss National Science Foundation (130823, 146133)
- Bundesministerium für Bildung und Forschung (FKZ 01ES0901, FKZ 01ES0802)
- Interdisciplinary Centre for Clinical Research, Universität of Würzburg, Germany (E-354)
- Interdisciplinary Centre for Clinical Research (E-32)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- inflammatory cardiomyopathy, myocarditis, peptide mimicry, commensal gut microbiota, Bacteroides, T helper cells, autoimmunity, heart failure, antibiotic therapy, mouse model
- MeSH terms
- Gastrointestinal Microbiome, Animals, Autoimmune Diseases, B-Lymphocytes, Bacteroides, beta-Galactosidase, Cardiomyopathy, Dilated, Disease Models, Animal, Humans, Intestines, Mice, Inbred BALB C, Mice, Transgenic, Myocarditis, Peptides, CD4-Positive T-Lymphocytes, Myosin Heavy Chains, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.